Adagene Non Currrent Assets Other vs Other Current Liab Analysis
ADAG Stock | USD 2.64 0.44 14.29% |
Adagene financial indicator trend analysis is way more than just evaluating Adagene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adagene is a good investment. Please check the relationship between Adagene Non Currrent Assets Other and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.
Non Currrent Assets Other vs Other Current Liab
Non Currrent Assets Other vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adagene Non Currrent Assets Other account and Other Current Liab. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Adagene's Non Currrent Assets Other and Other Current Liab is 0.11. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Adagene, assuming nothing else is changed. The correlation between historical values of Adagene's Non Currrent Assets Other and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Adagene are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Non Currrent Assets Other i.e., Adagene's Non Currrent Assets Other and Other Current Liab go up and down completely randomly.
Correlation Coefficient | 0.11 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Other Current Liab
Most indicators from Adagene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adagene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.At this time, Adagene's Enterprise Value Multiple is most likely to increase significantly in the upcoming years.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 1.1M | 1.4M | 1.2M | 1.3M | Interest Income | 76.2K | 377.5K | 4.3M | 4.5M |
Adagene fundamental ratios Correlations
Click cells to compare fundamentals
Adagene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Adagene fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 105.9M | 84.3M | 189.5M | 152.4M | 115.7M | 128.7M | |
Short Long Term Debt Total | 2.6M | 8.0M | 7.5M | 28.0M | 22.3M | 12.9M | |
Other Current Liab | 4.4M | 8.6M | 16.5M | 22.5M | 19.7M | 14.5M | |
Total Current Liabilities | 7.2M | 16.1M | 29.8M | 55.1M | 31.5M | 27.5M | |
Total Stockholder Equity | (57.0M) | (89.4M) | 156.6M | 83.1M | 70.6M | 74.1M | |
Net Tangible Assets | (57.0M) | (89.4M) | 156.6M | 83.1M | 95.6M | 100.3M | |
Property Plant And Equipment Net | 1.9M | 2.1M | 3.5M | 3.0M | 2.2M | 2.8M | |
Current Deferred Revenue | 993.4K | 725.5K | 5.5M | 15.1M | 52.9K | 50.2K | |
Net Debt | (90.0M) | (67.2M) | (166.9M) | (115.8M) | (87.6M) | (92.0M) | |
Retained Earnings | (63.3M) | (105.7M) | (178.8M) | (258.8M) | (277.8M) | (263.9M) | |
Accounts Payable | 712.7K | 1.8M | 3.3M | 3.7M | 3.1M | 2.4M | |
Cash | 92.5M | 75.2M | 174.4M | 143.8M | 109.9M | 112.2M | |
Non Current Assets Total | 2.0M | 5.2M | 3.6M | 3.1M | 2.3M | 3.4M | |
Non Currrent Assets Other | (109.8K) | (4.1M) | 69.3K | 109.6K | 84.9K | 89.1K | |
Other Assets | 87.2K | 3.1M | 69.3K | 109.6K | 1.0 | 0.95 | |
Cash And Short Term Investments | 100.5M | 75.2M | 174.4M | 143.8M | 109.9M | 119.7M | |
Net Receivables | 2.1M | 132.4K | 7.5M | 619.4K | 222.0K | 210.9K | |
Common Stock Shares Outstanding | 44.2M | 35.1M | 40.0M | 43.3M | 43.8M | 44.1M | |
Liabilities And Stockholders Equity | 105.9M | 84.3M | 189.5M | 152.4M | 115.7M | 128.7M | |
Non Current Liabilities Total | 155.7M | 157.5M | 3.1M | 14.2M | 13.7M | 13.0M | |
Other Current Assets | 1.2M | 3.8M | 4.1M | 4.9M | 3.3M | 3.4M | |
Other Stockholder Equity | (147.6M) | (137.8M) | 335.5M | 342.7M | 350.1M | 367.6M | |
Total Liab | 162.9M | 173.7M | 33.0M | 69.3M | 45.2M | 77.3M | |
Net Invested Capital | (54.5M) | (81.4M) | 164.0M | 110.9M | 92.5M | 97.1M | |
Property Plant And Equipment Gross | 1.9M | 2.1M | 3.5M | 3.0M | 8.9M | 9.4M | |
Short Long Term Debt | 1.0M | 5.0M | 4.5M | 13.6M | 8.4M | 6.4M | |
Total Current Assets | 103.9M | 79.1M | 186.0M | 149.3M | 113.4M | 125.3M | |
Accumulated Other Comprehensive Income | (344.9K) | (351.0K) | (94.0K) | (849.3K) | (1.8M) | (1.7M) | |
Capital Stock | 1.5K | 1.9K | 5.6K | 5.5K | 5.5K | 4.0K | |
Net Working Capital | 96.7M | 63.0M | 156.1M | 94.2M | 82.0M | 97.8M | |
Short Term Debt | 1.0M | 5.0M | 4.5M | 13.8M | 8.6M | 6.5M | |
Common Stock | 1.5K | 1.9K | 5.6K | 5.5K | 5.5K | 4.0K | |
Property Plant Equipment | 1.9M | 2.1M | 3.5M | 3.0M | 3.4M | 2.9M |
Currently Active Assets on Macroaxis
When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.85) | Return On Assets (0.20) | Return On Equity (0.46) |
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.